Part of GC Biopharma, delivering safe and effective therapies to patients worldwide.
Great Capabilities.
Bringing our extensive plasma technology, knowledge and expertise to the US.
Great Culture.
Our past success is the foundation of our future.
Latest News - 08.15.26
NEW - GC Biopharma USA has launched a new Medical Affairs webpage to support scientific exchange and provide medical and clinical information to the U.S. healthcare community. Explore: GCBiopharma.us/medical-affairs.
Latest News - 07.30.26
GC Biopharma Initiates Voluntary Market Withdrawal of Three Lots of Product
Latest News - 05.11.26
GC Biopharma Announces Lunch Symposium and Poster Presentations on IVIG Product Characterization at the 2026 CIS Annual Meeting
Latest News - 05.04.26
GC Biopharma Presents New Data at CIS 2026 to Expand Analytical Understanding of IVIG Product Characteristics
Latest News - 04.16.26
GC Biopharma Announces Presentation on Aggregation Profiles of Commercial IVIG Products at NHIA 2026
ALYGLO®
GC Biopharma Launches ALYGLO® - Now Available in the US Marketplace...
FDA Approval
GC Biopharma USA Announces US FDA Approval for ALYGLO®
Technology
Learn more about our CEX Chromatography manufacturing process
